MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjgast-2018-000209

Медицинская библиотека · BMJ open gastroenterology · 2018

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia.

Wei Bin, Ji Fanpu, Yeo Yee Hui, Ogawa Eiichi, Stave Christopher D, Dang Shuangsuo, Li Zongfang, Furusyo Norihiro, Cheung Ramsey C, Nguyen Mindie H

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Genotype 3 (GT3) is a common chronic hepatitis C (CHC) genotype in Asia. Direct-acting antiviral (DAA) regimens have high cure rates, but real-world results are limited for Asia.

AIM: To determine the real-world effectiveness of DAAs for patients with CHC GT3 in Asia.

METHODS

A systematic search was performed in PubMed (including MEDLINE), Embase, and selected international meeting abstract repositories. Eligible studies were postmarketing observational studies from Asia with the primary outcome of sustained virological response 12 weeks after completion of treatment (SVR12).

RESULTS

A total of 15 studies with 4230 patients yielded a pooled SVR12 of 92.7%. High heterogeneity (I2=93.2%, P<0.0001) was noted. In subgroup analyses, patients with cirrhosis had 10.9% lower SVR12 than non-cirrhotic patients (88.6% vs 98.9%; P<0.0001) and contributed 69.5% of the heterogeneity. Prior treatment failure did not reduce the pooled SVR12 (treatment-naïve: 94.6%, 95% CI 91.3% to 96.7% vs treatment-experienced: 94.0%, 95% CI 77.5% to 98.6%; P=0.89). Twenty-four weeks of sofosbuvir+ribavirin dual therapy was the most commonly used regimen which led to similar SVR12 (OR=1.1, P=0.73) but lower adverse event rate than 12 weeks of sofosbuvir+ribavirin+pegylated interferon triple therapy.

CONCLUSION

Sofosbuvir+ribavirin for 24 weeks is the most widely used and generally well-tolerated DAA therapy in Asia. However, its effectiveness is not optimal in GT3 patients with cirrhosis.

Для цитирования: Wei Bin, Ji Fanpu, Yeo Yee Hui, Ogawa Eiichi, Stave Christopher D, Dang Shuangsuo, Li Zongfang, Furusyo Norihiro, Cheung Ramsey C, Nguyen Mindie H. Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia.. BMJ open gastroenterology. 2018. DOI: 10.1136/bmjgast-2018-000209.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.